|
Market Cap (2-Jul) $363,897,504 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 1 August 2022, 7:55. The announcement is marked as price sensitive, and is 4 page(s) in length and 351.3kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.864% short sold according to ASIC data. It was ranked the 232nd most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| TACTI-002 2nd line lung cancer data presented at 2022 WCLC | 1 August 2022, 7:55 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 July 2022, 10:07 |
| Notification of cessation of securities - IMM | 14 July 2022, 17:25 |
| Immutep granted Japanese Patent for IMP761 | 6 July 2022, 8:22 |
You must be logged in to post a reply.
